--- a
+++ b/clusters/9knumclustersv2/clust_1155.txt
@@ -0,0 +1,35 @@
+Absolute lymphocyte count (ALC) ? /mm
+Absolute lymphocyte count (ALC) </L.
+Absolute lymphocyte count (ALC) >/L
+Adequate organ function within  days of study registration including:\r\n* Absolute lymphocyte count (ALC) >= . x ^/L
+Absolute lymphocyte count (ALC) >= / mm^
+Absolute lymphocyte count (ALC) >=  cells/ul
+PART I: Absolute lymphocyte count (ALC) >=  cells/mm^
+PART II: ALC >=  cells/mm^
+Absolute lymphocyte count (ALC) of > , K/uL
+Absolute lymphocyte count (ALC) ? /mm^, and absolute number of CD+ T cells > /mm^
+Absolute blood lymphocyte (ALC) >=  cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement
+Absolute blood lymphocyte (ALC) >=  cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement
+Absolute lymphocyte count (ALC) >= . x ^/L.
+Absolute lymphocyte count (ALC) > cells/mm
+Absolute lymphocyte count (ALC) >= /mm^
+Patient must have no persistent toxicities from prior therapy >= grade  with the exception of\r\nhematologic indices (i.e., hemoglobin, white blood cell count [WBC], ANC, absolute lymphocyte count [ALC])
+Absolute lymphocyte count (ALC) >= /uL
+Absolute lymphocyte count (ALC) >=  cells/ul
+Absolute lymphocyte count (ALC) > 
+Patients must have absolute lymphocyte counts (ALC) of more than , cell/mm^
+Absolute lymphocyte count (ALC) > /ul
+Absolute lymphocyte count (ALC) >= /mm^
+Absolute T-cell count (ATC) at screening >= . K/microL. This is defined as CD+ T-cell percent (expressed as fraction of %) multiplied by the absolute lymphocyte count (ALC, expressed in K/microL).
+Absolute lymphocyte count (ALC) >= /uL
+Absolute lymphocyte count (ALC) ? /mm
+Progressive lymphocytosis in the absence of infection, with an increase in blood Absolute Lymphocyte Count (ALC) >=% over a -month period, or a lymphocyte doubling time (LDT) of < months (as long as initial ALC was >=/l).
+either ALC > /L, or
+Absolute lymphocyte count (ALC) ?   e/L
+Patients with a diagnosis of CLL (any stage) with absolute lymphocyte count (ALC) >=  x /l, requiring therapy
+Absolute lymphocyte count (ALC) >= /uL obtained =<  days prior to registration
+For Phase b individuals: absolute lymphocyte count (ALC) > /?L in peripheral blood.
+Absolute lymphocyte count (ALC) >= . X ^/L
+Absolute lymphocyte count (ALC) >= /?L
+ALC >/uL
+Absolute lymphocyte count (ALC) ? ,/?l (? /?l after stem cell transplant) Note: After completion of dose escalation, patients with AML are not required to meet these hematologic criteria.